Boule Diagnostics AB (publ)

Stockholm Stock Exchange BOUL.ST

Boule Diagnostics AB (publ) Price to Sales Ratio (P/S) on January 14, 2025: 0.61

Boule Diagnostics AB (publ) Price to Sales Ratio (P/S) is 0.61 on January 14, 2025, a -20.34% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Boule Diagnostics AB (publ) 52-week high Price to Sales Ratio (P/S) is 0.80 on January 22, 2024, which is 31.69% above the current Price to Sales Ratio (P/S).
  • Boule Diagnostics AB (publ) 52-week low Price to Sales Ratio (P/S) is 0.42 on November 13, 2024, which is -31.60% below the current Price to Sales Ratio (P/S).
  • Boule Diagnostics AB (publ) average Price to Sales Ratio (P/S) for the last 52 weeks is 0.60.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
Stockholm Stock Exchange: BOUL.ST

Boule Diagnostics AB (publ)

CEO Mr. Torben Nielsen
IPO Date June 23, 2011
Location Sweden
Headquarters Domnarvsgatan 4
Employees 200
Sector Health Care
Industries
Description

Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. The company provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning products under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer and diagnostics systems under the Exigo brand. It sells its products directly in Sweden and the United States, as well as through distributors internationally. The company serves hospitals, clinics, laboratories, healthcare centers and veterinary clinics, and other diagnostics companies. It has operations in Sweden, the United States, Mexico, and Russia. The company was founded in 1956 and is headquartered in Spånga, Sweden.

Similar companies

BIOT.ST

Biotage AB (publ)

USD 11.98

-2.51%

CRAD-B.ST

C-Rad AB (publ)

USD 2.57

-0.02%

CEVI.ST

CellaVision AB (publ)

USD 18.76

3.89%

BIOG-B.ST

BioGaia AB (publ)

USD 9.75

-0.95%

CTT.ST

CTT Systems AB (publ)

USD 23.79

-0.07%

StockViz Staff

January 15, 2025

Any question? Send us an email